Product information and disease descriptionProduct descriptionProduct informationPharmacology
Pharmacodynamics
9 evidence topics · 9 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionProduct descriptionProduct informationPharmacology
9 evidence topics · 9 sources